Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine

Journal of Nephrology

Volumn 21, Issue 4, 2008, Pages 535-542

  Peng, Wenhan ^a   Chen, Jianghua ^a   Jiang, Yuguang ^a   Shou, Zhangfei ^a   Chen, Ying ^a   Wang, Huiping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Rejection; Serum; Transplantation; Urine; Vascular endothelial growth factor

Indexed keywords

CREATININE; CYCLOSPORIN; TACROLIMUS; VASCULOTROPIN; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT; VASCULOTROPIN A;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BIOPSY; BLOOD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FOLLOW UP; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; ROC CURVE; URINE;

ADULT; BIOLOGICAL MARKERS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; ROC CURVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 52649094404     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Keith DS, Mattos A, Golconda M, et al. Factors associated with improvement in deceased donor renal allograft function in the 1990s. J Am Soc Nephrol. 2005;16:1512-1521.
2. Yates PJ, Nicholson ML. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol. 2006;16:148-157.
3. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713-723.
4. Wittke S, Haubitz M, Walden M, et al. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant. 2005;5:2479-2488.
5. Karpinski M, Rush D, Jeffery J, Pochinco D, Milley D, Nickerson P. Heightened peripheral blood lymphocyte CD69 expression is neither sensitive nor specific as a noninvasive diagnostic test for renal allograft rejection. J Am Soc Nephrol. 2003;14:226-233.
6. Thongboonkerd V, Mcleish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002;62:1461-1469.
7. Pieper R, Gatlin CL, Mcgrath AM, et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 2004;4:1159-1174.
8. Hsieh HG, Loong CC, Lui WY, Chen A, Lin CY. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int. 2001;14:287-298.
9. Voshol H, Brendlen N, Muller D, et al. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. Proteomics. 2005;4:1192-1199.
10. Hauser IA, Spiegler S, Kiss E, et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-γ (MIG). J Am Soc Nephrol. 2005;16:1849-1858.
11. Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001;106:148-156.
12. Whittle C, Gillespie K, Harrison R, Mathieson PW, Harper SJ. Heterogeneous (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci. 1999;97:303-312.
13. Bailey E, Bottomley MJ, Mestwell S, et al. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridization. J Clin Pathol. 1999;52:735-738.
14. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.
15. Ferrara N, Keyt B. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res. 2000;55:15-35.
16. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor kappa B and induced monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes. 1999;48:1131-1137.
17. Kim I, Moon SO, Kim SH, Koh YS, Koh GY. VEGF stimulates expression of ICAM-1, VCAM-1 and E-selectin through nuclear factor kappa B activation in endothelial cells. J Biol Chem. 2001;276:7614-7620.
18. Pilmore HL, Eris JM, Painter DM, Bishop GA, McCaughan GW. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation. 1999;67:929-933.
19. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation. 2004;78:242-249.
20. Shisedo S, Asanumu H, Nakai H, et al. The impact repeated subclinical rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol. 2003;14:1046-1052.
21. Veronese FV, Noronha IL, Manfro RC, Edelweiss MI, Goldberg J, Goncalves LF. Prevalence and immunohisto-chemical findings of subclinical kidney allograft rejection and its association with graft outcome. Clin Transplant. 2004;18:357-364.
22. Aquino Dias EC, Veronese FJ, Santos Goncalves LF, Manfro RC. Molecular markers in subclinical acute rejection of renal transplants. Clin Transplant. 2004;18:281-287.
23. Nankivell BJ, Fenton-Lee CA, Kuypers DR, et al. Effect of histological damage on long term kidney transplant outcome. Transplantation. 2001;71:515-523.
24. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349:2326-2333.
25. Lazzeri E, Rotondi M, Mazzinghi B, et al. High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. Transplantation. 2005;79:1215-1220.
26. Lederer SR, Friedrich N, Regenbogen C, Getto R, Toepfer M, Sitter T. Non-invasive monitoring of renal transplant recipients: urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Pract. 2003;94:19-26.
27. Peng W, Chen J, Jiang Y, Shou Z, Chen Y, Wang H. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine. Nephrology (Carlton). 2008;13:73-79.
28. Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthesis pathway. Am J Pathol. 1998;153:587-598.
29. Ozdemir BH, Ozdemir FN, Gungen Y, Haberal M. Role of macrophages and lymphocytes in the induction of neovascularisation in renal allograft rejection. Am J Kidney Dis. 2002;39:347-353.
30. Bottomley MJ, Webb NJ, Watson CJ, et al. Placenta growth factor (PIGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol. 2000;119:182-188.
31. Sartelet H, Toupance O, Lorenzato M, et al. Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am J Transplant. 2005;5:2441-2447.
32. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophage and angiogenesis. J Leukoc Biol. 1994;55:410-412.
33. Avihingsanon Y, Phumesin P, Benjachat T, et al. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Kidney Int. 2006;69:747-753.